206 related articles for article (PubMed ID: 27354067)
1. Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.
Wang Y; Cai KQ; Smith ER; Yeasky TM; Moore R; Ganjei-Azar P; Klein-Szanto AJ; Godwin AK; Hamilton TC; Xu XX
Mol Cell Biol; 2016 Sep; 36(18):2418-30. PubMed ID: 27354067
[TBL] [Abstract][Full Text] [Related]
2. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice.
Cai KQ; Wang Y; Smith ER; Smedberg JL; Yang DH; Yang WL; Xu XX
Neoplasia; 2015 Jan; 17(1):89-100. PubMed ID: 25622902
[TBL] [Abstract][Full Text] [Related]
3. Development of a mouse model of menopausal ovarian cancer.
Smith ER; Wang Y; Xu XX
Front Oncol; 2014; 4():36. PubMed ID: 24616881
[TBL] [Abstract][Full Text] [Related]
4. White spotting variant mouse as an experimental model for ovarian aging and menopausal biology.
Smith ER; Yeasky T; Wei JQ; Miki RA; Cai KQ; Smedberg JL; Yang WL; Xu XX
Menopause; 2012 May; 19(5):588-96. PubMed ID: 22228319
[TBL] [Abstract][Full Text] [Related]
5. Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas.
Quartuccio SM; Lantvit DD; Bosland MC; Burdette JE
PLoS One; 2013; 8(5):e65067. PubMed ID: 23741457
[TBL] [Abstract][Full Text] [Related]
6. Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletion.
Smith ER; Xu XX
Lancet Oncol; 2008 Nov; 9(11):1108-11. PubMed ID: 19012860
[TBL] [Abstract][Full Text] [Related]
7. p27kip1 (cyclin-dependent kinase inhibitor 1B) controls ovarian development by suppressing follicle endowment and activation and promoting follicle atresia in mice.
Rajareddy S; Reddy P; Du C; Liu L; Jagarlamudi K; Tang W; Shen Y; Berthet C; Peng SL; Kaldis P; Liu K
Mol Endocrinol; 2007 Sep; 21(9):2189-202. PubMed ID: 17565040
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.
Cai KQ; Wu H; Klein-Szanto AJ; Xu XX
Gynecol Oncol; 2009 Jul; 114(1):18-25. PubMed ID: 19375154
[TBL] [Abstract][Full Text] [Related]
9. A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in Wv mice.
Yang WL; Cai KQ; Smedberg JL; Smith ER; Klein-Szanto A; Hamilton TC; Xu XX
Am J Pathol; 2007 Apr; 170(4):1325-36. PubMed ID: 17392171
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-1 inhibition prolongs postnatal ovarian follicle lifespan in mice.
Smith ER; Yang WL; Yeasky T; Smedberg J; Cai KQ; Xu XX
Biol Reprod; 2013 Oct; 89(4):103. PubMed ID: 23966321
[TBL] [Abstract][Full Text] [Related]
11. Induction of a menopausal state alters the growth and histology of ovarian tumors in a mouse model of ovarian cancer.
Laviolette LA; Ethier JF; Senterman MK; Devine PJ; Vanderhyden BC
Menopause; 2011 May; 18(5):549-57. PubMed ID: 21221022
[TBL] [Abstract][Full Text] [Related]
12. Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models.
Capo-chichi CD; Yeasky TM; Heiber JF; Wang Y; Barber GN; Xu XX
Gynecol Oncol; 2010 Feb; 116(2):269-75. PubMed ID: 19932656
[TBL] [Abstract][Full Text] [Related]
13. Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas.
Clark-Knowles KV; Senterman MK; Collins O; Vanderhyden BC
PLoS One; 2009 Dec; 4(12):e8534. PubMed ID: 20046869
[TBL] [Abstract][Full Text] [Related]
14. A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.
Xing D; Orsulic S
Cancer Res; 2006 Sep; 66(18):8949-53. PubMed ID: 16982732
[TBL] [Abstract][Full Text] [Related]
15. Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts.
Chen CM; Chang JL; Behringer RR
Oncogene; 2004 Oct; 23(46):7722-5. PubMed ID: 15334065
[TBL] [Abstract][Full Text] [Related]
16. MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis.
Wang CK; Chen TJ; Tan GYT; Chang FP; Sridharan S; Yu CA; Chang YH; Chen YJ; Cheng LT; Hwang-Verslues WW
Cancer Res; 2023 Jan; 83(2):251-263. PubMed ID: 36354374
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
Kurman RJ; Shih IeM
Hum Pathol; 2011 Jul; 42(7):918-31. PubMed ID: 21683865
[TBL] [Abstract][Full Text] [Related]
18. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.
Flesken-Nikitin A; Choi KC; Eng JP; Shmidt EN; Nikitin AY
Cancer Res; 2003 Jul; 63(13):3459-63. PubMed ID: 12839925
[TBL] [Abstract][Full Text] [Related]
19. Conditional knockout of brca1/2 and p53 in mouse ovarian surface epithelium: do they play a role in ovarian carcinogenesis?
Kim KY; Park DW; Jeung EB; Choi KC
J Vet Sci; 2010 Dec; 11(4):291-7. PubMed ID: 21113097
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors.
Lee WS; Park ES; Kim DH; Kim TH; Lee HH; Chung SH
Eur J Gynaecol Oncol; 2012; 33(4):358-62. PubMed ID: 23091890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
